Jay Achar
About me
I trained as a medical doctor at University College London before moving to Melbourne, Australia to complete my specialist training in Internal Medicine and Infectious Diseases. Over the past decade, I have gained extensive international experience in low resource settings both in health programming and operational research. Following an intensive 18 months supporting West African Ebola interventions in Sierra Leone, Liberia and Guinea, my work has focused more strongly on TB and HIV both in the ex-CIS countries (Belarus, Russia, Armenia, Georgia, Uzbekistan, Tajikistan) and in sub-Saharan Africa (South Sudan, DR Congo, Chad).
Within the TB community, I have contributed to a number of policy and consultation documents to help improve the support given to national programmes and continue to participate in a wide range of initiatives to train colleagues who treat people suffering with TB. After completing my specialist training, I have been awarded a MSc with distinction in Epidemiology from the London School of Hygiene and Tropical Medicine and have received a Diploma in Tropical Medicine and Hygiene from the Royal College of Physicians, London.
Diploma in Tropical Medicine and Hygiene - Royal College of Physicians, London
Masters in Epidemiology (MSc) - London School of Hygiene and Tropical Medicine
Fellow of the Royal College of Australian Physicians (FRACP) - Infectious Diseases
Bachelor of Medicine and Surgery (MBBS) - University College London
Research
- Funded by Venenskapsrådet (Swedish Research Council), my PhD project will
investigate the ability of aerosol detection of tuberculosis to predict
household transmission. The project includes a number of laboratory and
clinical studies in Sweden, South Africa and Mozambique establishing the
performance of a new device to detect aerosolised pathogens and to then
investigate the association between detection in adult patients and
transmission within the household.
I continue to collaborate with old colleagues in a number of academic
institutions in the field of TB both to contribute to a chronically
underfunded and poorly understood research field and to learn new things from
experienced collaborators. I am particularily interested in the treatment of
drug-resistant tuberculosis in adults and children as well as the impact of
treatment of TB infection.
After working with large quantities of diverse data, I believe strongly in
the role of well managed data in supporting health-related decision making. I
have extensive practical experience in data collection and data management in
challenging environments and have built on the knowledge of
regression modelling I gained during my MSc.
Articles
- Article: THE LANCET INFECTIOUS DISEASES. 2024;24(10):1151-1161
- Article: IJTLD OPEN. 2024;1(7):285-291
- Article: GLOBALIZATION AND HEALTH. 2024;20(1):51
- Article: IJTLD OPEN. 2024;1(3):103-110
- Article: INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE. 2023;27(10):748-753
- Article: INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE. 2023;27(8):584-598
- Article: JOURNAL OF PUBLIC HEALTH. 2023;45(2):481-487
- Article: MICROBIOLOGY SPECTRUM. 2023;11(1):e0369822-e03622
- Article: PLOS GLOBAL PUBLIC HEALTH. 2023;3(4):e0000818
- Article: THE LANCET GLOBAL HEALTH. 2022;10(12):e1774-e1781
- Article: PLOS GLOBAL PUBLIC HEALTH. 2022;2(8):e0000567
- Article: ERJ OPEN RESEARCH. 2022;8(1):622-2021
- Article: TROPICAL MEDICINE AND INTERNATIONAL HEALTH. 2021;26(4):421-427
- Article: MONALDI ARCHIVES FOR CHEST DISEASE. 2021;91(1)
- Article: MONALDI ARCHIVES FOR CHEST DISEASE. 2021;91(1)
- Article: ERJ OPEN RESEARCH. 2021;7(1):537-2020
- Article: BMC INFECTIOUS DISEASES. 2020;20(1):675
- Article: EUROPEAN RESPIRATORY JOURNAL. 2020;55(3):1901467
- Article: PLOS ONE. 2020;15(11):e0242359
- Article: PLOS MEDICINE. 2018;15(7):e1002591
- Article: INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE. 2018;22(5):544-550
- Article: EMERGING INFECTIOUS DISEASES. 2017;23(10):1711-1713
- Article: JOURNAL OF THE INTERNATIONAL AIDS SOCIETY. 2017;20(Suppl 4):21654
- Article: PLOS ONE. 2017;12(5):e0176692
- Article: BMC MEDICINE. 2016;14(1):187
- Journal article: F1000RESEARCH. 2016;5:1477
- Article: THE LANCET GLOBAL HEALTH. 2016;4(7):e495-e501
- Article: INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE. 2016;20(4):474-478
- Article: EMERGING INFECTIOUS DISEASES. 2016;22(2):217-223
- Article: F1000RESEARCH. 2016;5:1477
- Show more
All other publications
- Letter: EUROPEAN RESPIRATORY JOURNAL. 2023;62(5):2300969
- Review: PATHOGENS. 2022;11(4):381
- Review: BMC INFECTIOUS DISEASES. 2020;20(1):298
- Review: EMERGING INFECTIOUS DISEASES. 2019;25(3):441-450
- Review: AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2017;195(10):1300-1310
- Letter: THE LANCET. 2016;388(10057):2234
- Letter: EMERGING INFECTIOUS DISEASES. 2015;21(11):2105-2106
- Review: OBSTETRIC MEDICINE. 2015;8(3):108-113